EMN Eastman Chemical (EMN) Insider Trading, Ownership & Congress Trades
Materials · Plastic materials, synth resins & nonvulcan elastomers · CIK 0000915389
Form 144 · 1
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
333
13F, latest reported quarter
What the filings say about EMN
Insiders, 180 days
-$365.8K net sold
1 seller · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-08-04
Planned sales (Form 144), 90 days
$234.1K
1 notice
Eastman Chemical insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, EASTMAN CHEMICAL CO insiders sold a net $365.8K of stock across 48 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on May 5, 2026.
- No other insider sold within 30 days.
- 333 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Chf HR Ofcr Holt Adrian James sold about $234.1K of EMN on Aug 4, 2026, the largest insider sale at the company since 2025; 333 funds added in the latest 13F quarter.Context
- 8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Feb 20, 2025.
- No other insider sold within 30 days.
- 333 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Chf HR Ofcr Holt Adrian James sold about $131.7K of EMN on May 5, 2026, the largest insider sale at the company since 2025; 333 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 10.5% of the 16,732 shares held after it.
- 10 other insiders bought within 30 days.
- 333 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, AFP, Mfg., WWEC & HSE SMITH BRIAN TRAVIS bought about $119.6K of EMN on Aug 27, 2025, the largest insider purchase at the company on our record; 10 other insiders bought within 30 days and 333 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 21.2% of the 6,828 shares held after it.
- 10 other insiders bought within 30 days.
- 333 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director OBRIEN JAMES J /KY bought about $99.8K of EMN on Aug 27, 2025, the largest insider purchase at the company on our record; 10 other insiders bought within 30 days and 333 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 51.1% of the 2,840 shares held after it.
- 10 other insiders bought within 30 days.
- 333 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Mink Kim Ann bought about $100.6K of EMN on Aug 27, 2025, the largest insider purchase at the company on our record; 10 other insiders bought within 30 days and 333 funds added in the latest 13F quarter.48 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$365.8K over 180 days
-$234.1K over 90 days
below 57% of Materials
Congress
no House purchase disclosed in the last 12 months
Funds
333 funds bought in last quarter
more than 85% of Materials
Revenue
-6.7% year over year
below 76% of Materials
Margin
5.4% net margin
more than 65% of Materials
Buybacks
no share repurchases reported
Short interest
5.5% of the float short (float per yahoo 2026-10-27) · 4.2 days to cover · settled 2026-10-15
more than 70% of Materials
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch EMN
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+8.0%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns EMN: institutional holders (13F)
13F holdings, latest reported quarter
16,936,709 sh
$1.1B
7,553,898 sh
$506.0M
5,163,630 sh
$345.9M
5,160,164 sh
$345.6M
4,169,105 sh
$282.7M
Congress trades in EMN
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-08-04 · disclosed 39 days later
$1,001 - $15,000
Bought 2025-06-17 · disclosed 57 days later
$1,001 - $15,000
Sold 2025-05-15 · disclosed 25 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
EMN planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Holt Adrian James
Filed 2026-08-04
$234.1K
EMN mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Invesco S&P SmallCap Materials ETF
$2.3M position · as of 2026-05-31
10.9%
Amplify Energy & Natural Resources Covered Call ETF
$1.2M position · as of 2026-06-30
4.8%
First Trust Materials AlphaDEX Fund
$13.1M position · as of 2026-07-31
3.6%
Motley Fool Small-Cap Growth ETF
$1.5M position · as of 2026-05-31
2.5%
Select Chemicals Portfolio
$8.9M position · as of 2026-05-31
2.0%
DAVENPORT VALUE & INCOME FUND
$20.5M position · as of 2026-06-30
2.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Eastmanpac-Political Action Committee Of Eastman Chemical Company
Cycle 2026 · $261K spent
$298.2K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Mark J. Costa
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$19.5M
-$5.8M
$5.1M
-24%
+19%
2024
$15.9M
$22.8M
$4.6M
+4%
+22%
2023
$17.6M
$17.0M
$4.8M
-1%
+24%
2022
$17.1M
$12.0M
$4.4M
-14%
+11%
2021
$17.8M
$33.7M
$5.4M
+24%
+26%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $365.8K sold by insiders over 180 days, 333 funds added last quarter, $234.1K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
EMN financials
Revenue growth
-6.7%
XBRL, annual
Net margin
5.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$8.9B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM EMN
| FY Dec 2025 | $8.8B |
| FY Dec 2024 | $9.4B |
| FY Dec 2023 | $9.2B |
| FY Dec 2022 | $10.6B |
| FY Dec 2021 | $10.5B |
| Jun 2026 | $2.5B |
| Mar 2026 | $2.2B |
| Dec 2025 | $2.0B |
| Sep 2025 | $2.2B |
| Jun 2025 | $2.3B |
| Mar 2025 | $2.3B |
| Dec 2024 | $2.2B |
| Sep 2024 | $2.5B |
At each fiscal year end
Single quarter
Net margin, TTM
+5.0%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM EMN
| FY Dec 2025 | +5.4% |
| FY Dec 2024 | +9.6% |
| FY Dec 2023 | +9.7% |
| FY Dec 2022 | +7.5% |
| FY Dec 2021 | +8.2% |
| Jun 2026 | +7.3% |
| Mar 2026 | +4.9% |
| Dec 2025 | +5.3% |
| Sep 2025 | +2.1% |
| Jun 2025 | +6.1% |
| Mar 2025 | +7.9% |
| Dec 2024 | +14.7% |
| Sep 2024 | +7.3% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$539.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM EMN
| FY Dec 2025 | $424.0M |
| FY Dec 2024 | $688.0M |
| FY Dec 2023 | $546.0M |
| FY Dec 2022 | $364.0M |
| FY Dec 2021 | $1.1B |
| Jun 2026 | $124.0M |
| Mar 2026 | -$240.0M |
| Dec 2025 | $390.0M |
| Sep 2025 | $265.0M |
| Jun 2025 | $83.0M |
| Mar 2025 | -$314.0M |
| Dec 2024 | $361.0M |
| Sep 2024 | $276.0M |
At each fiscal year end
Single quarter
Debt to equity
0.86x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity EMN
| FY Dec 2025 | 0.80x |
| FY Dec 2024 | 0.87x |
| FY Dec 2023 | 0.89x |
| FY Dec 2022 | 1.00x |
| FY Dec 2021 | 0.90x |
| Jun 2026 | 0.86x |
| Mar 2026 | 0.87x |
| Dec 2025 | 0.80x |
| Sep 2025 | 0.88x |
| Jun 2025 | 0.88x |
| Mar 2025 | 0.86x |
| Dec 2024 | 0.87x |
| Sep 2024 | 0.89x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.19x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt EMN
| FY Dec 2025 | 0.20x |
| FY Dec 2024 | 0.26x |
| FY Dec 2023 | 0.28x |
| FY Dec 2022 | 0.19x |
| FY Dec 2021 | 0.31x |
| Jun 2026 | 0.19x |
| Mar 2026 | 0.19x |
| Dec 2025 | 0.20x |
| Sep 2025 | 0.20x |
| Jun 2025 | 0.20x |
| Mar 2025 | 0.23x |
| Dec 2024 | 0.26x |
| Sep 2024 | 0.24x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+7.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity EMN
| FY Dec 2025 | +8.1% |
| FY Dec 2024 | +16.1% |
| FY Dec 2023 | +16.9% |
| FY Dec 2022 | +14.6% |
| FY Dec 2021 | +14.6% |
| Jun 2026 | +7.4% |
| Mar 2026 | +6.7% |
| Dec 2025 | +8.1% |
| Sep 2025 | +12.2% |
| Jun 2025 | +14.5% |
| Mar 2025 | +16.2% |
| Dec 2024 | +16.1% |
| Sep 2024 | +16.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets EMN
| FY Dec 2025 | +3.2% |
| FY Dec 2024 | +6.1% |
| FY Dec 2023 | +6.1% |
| FY Dec 2022 | +5.3% |
| FY Dec 2021 | +5.4% |
| Jun 2026 | +2.9% |
| Mar 2026 | +2.6% |
| Dec 2025 | +3.2% |
| Sep 2025 | +4.7% |
| Jun 2025 | +5.5% |
| Mar 2025 | +6.2% |
| Dec 2024 | +6.1% |
| Sep 2024 | +6.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+12.0%
operating income after a 17.7% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital EMN
| FY Dec 2025 | +12.9% |
| FY Dec 2024 | +13.0% |
| FY Dec 2023 | +13.1% |
| FY Dec 2022 | +12.4% |
| FY Dec 2021 | +11.7% |
| Jun 2026 | +12.0% |
| Mar 2026 | +13.0% |
| Dec 2025 | +12.9% |
| Sep 2025 | +12.5% |
| Jun 2025 | +12.6% |
| Mar 2025 | +12.7% |
| Dec 2024 | +13.0% |
| Sep 2024 | +11.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+12.1%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed EMN
| FY Dec 2025 | +12.4% |
| FY Dec 2024 | +12.5% |
| FY Dec 2023 | +13.1% |
| FY Dec 2022 | +12.8% |
| FY Dec 2021 | +11.5% |
| Jun 2026 | +12.1% |
| Mar 2026 | +12.2% |
| Dec 2025 | +12.4% |
| Sep 2025 | +12.1% |
| Jun 2025 | +12.2% |
| Mar 2025 | +12.3% |
| Dec 2024 | +12.5% |
| Sep 2024 | +12.5% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
17.12x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing EMN
| FY Dec 2025 | 15.61x |
| FY Dec 2024 | 11.91x |
| FY Dec 2023 | 12.01x |
| FY Dec 2022 | 12.76x |
| FY Dec 2021 | 19.19x |
| Jun 2026 | 17.44x |
| Mar 2026 | 22.12x |
| Dec 2025 | 15.61x |
| Sep 2025 | 10.54x |
| Jun 2025 | 10.50x |
| Mar 2025 | 11.22x |
| Dec 2024 | 11.91x |
| Sep 2024 | 15.01x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$12.2B
market value at close 2026-10-26 on 2026-06-30 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2025-12-31
Enterprise value EMN
| FY Dec 2025 | $11.5B |
| FY Dec 2024 | $14.7B |
| FY Dec 2023 | $14.8B |
| FY Dec 2022 | $14.3B |
| FY Dec 2021 | $20.3B |
| Jun 2026 | $12.3B |
| Mar 2026 | $13.4B |
| Dec 2025 | $11.5B |
| Sep 2025 | $11.4B |
| Jun 2025 | $12.9B |
| Mar 2025 | $14.4B |
| Dec 2024 | $14.7B |
| Sep 2024 | $17.5B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+7.2%
TTM free cash flow over market value at close 2026-10-26
FCF yield EMN
| FY Dec 2025 | +5.8% |
| FY Dec 2024 | +6.5% |
| FY Dec 2023 | +5.2% |
| FY Dec 2022 | +3.8% |
| FY Dec 2021 | +6.8% |
| Jun 2026 | +7.0% |
| Mar 2026 | +5.7% |
| Dec 2025 | +5.8% |
| Sep 2025 | +5.5% |
| Jun 2025 | +4.7% |
| Mar 2025 | +5.7% |
| Dec 2024 | +6.5% |
| Sep 2024 | +4.6% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -46%, PEG needs growth
PEG, trailing EMN
| FY Dec 2025 | n/a |
| FY Dec 2024 | 4.69x |
| FY Dec 2023 | 0.70x |
| FY Dec 2022 | 10.05x |
| FY Dec 2021 | 0.24x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | 8.70x |
| Dec 2024 | 4.69x |
| Sep 2024 | 0.30x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $8.8B | $9.4B | $9.2B | $10.6B |
| Gross profit | $1.8B | $2.3B | $2.1B | $2.1B |
| Net income | $474.0M | $905.0M | $894.0M | $793.0M |
| EPS (diluted) | 4.10 | 7.67 | 7.49 | 6.35 |
| Operating cash flow | $970.0M | $1.3B | $1.4B | $975.0M |
| Cash | $566.0M | $837.0M | $548.0M | $493.0M |
| Long-term debt | $4.2B | $4.6B | $4.3B | $4.0B |
| Dividends paid | $381.0M | $379.0M | $376.0M | $381.0M |
SEC XBRL, fiscal years, as known on 2026-10-28
EMN Stock Sonar score 6/7 axes
Find similar shapesCompareEMN ranks highest on institutional and government (93rd percentile) and profitability (63rd), and lowest on insider conviction (21st), among Materials peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
EMN filings, in plain words
Are Eastman Chemical insiders buying or selling EMN?
In the 180 days to 2026-10-28, Eastman Chemical insiders were net sellers, a net $365.8K across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded EMN?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Lisa McClain dated 2025-08-04.
Are there planned insider sales of EMN?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $234.1K of stock; the latest, by Holt Adrian James, was filed 2026-08-04.
Read the full summary
In the 180 days to 2026-10-28, Eastman Chemical insiders were net sellers of EMN, a net $365.8K across purchases and sales reported on Form 4 by 1 seller. Members of Congress have disclosed trades in EMN, none in the last year; the latest on record is a sale by Lisa McClain dated 2025-08-04. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $234.1K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
